GRAIL, Inc. SEC filings GRAL
GRAIL, Inc. has 265 filings in SEC EDGAR's recent list, going back to Mar 14, 2017. Its latest annual report, Form 10-K, was filed on Mar 12, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 6, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Results of operations
|
Nov 4, 2026 | Nov 4, 2026 |
| 10-Q | Quarterly report | Aug 6, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 5, 2026 | Aug 5, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Jun 22, 2026 | Jun 18, 2026 |
| 8-K |
Current report
Officer or director change, Other events
|
Jun 1, 2026 | Jun 1, 2026 |
| 10-Q | Quarterly report | May 7, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations
|
May 5, 2026 | May 5, 2026 |
| DEFA14A | Additional proxy material | Apr 28, 2026 | — |
| DEF 14A | Proxy statement | Apr 28, 2026 | Jun 18, 2026 |
| S-8 | Employee stock plan registration | Mar 12, 2026 | — |
| 10-K | Annual report | Mar 12, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Results of operations, Other events
|
Feb 19, 2026 | Feb 19, 2026 |
| 8-K |
Current report
Results of operations
|
Jan 12, 2026 | Jan 12, 2026 |
| 8-K |
Current report
Other events
|
Nov 14, 2025 | Nov 13, 2025 |
| 424B5 | Prospectus supplement | Nov 14, 2025 | — |
| 424B7 | Filing | Nov 13, 2025 | — |
| S-3ASR | Automatic shelf registration | Nov 13, 2025 | — |
| 10-Q | Quarterly report | Nov 13, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 12, 2025 | Nov 12, 2025 |
| D | Filing | Nov 7, 2025 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Oct 20, 2025 | Oct 18, 2025 |
| 8-K |
Current report
Material agreement, Results of operations, Unregistered share sale, Regulation FD disclosure
|
Oct 16, 2025 | Oct 16, 2025 |
| 8-K |
Current report
Material agreement, New debt
|
Sep 18, 2025 | Sep 11, 2025 |
| 10-Q | Quarterly report | Aug 13, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 12, 2025 | Aug 12, 2025 |
| 8-K |
Current report
Shareholder vote results
|
May 30, 2025 | May 29, 2025 |
| 8-K |
Current report
Officer or director change
|
May 16, 2025 | May 16, 2025 |
| S-8 | Employee stock plan registration | May 14, 2025 | — |
| 10-Q | Quarterly report | May 14, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Results of operations
|
May 13, 2025 | May 13, 2025 |
| DEF 14A | Proxy statement | Apr 15, 2025 | May 29, 2025 |
| DEFA14A | Additional proxy material | Apr 15, 2025 | — |
| DEF 14A | Proxy statement | Apr 15, 2025 | May 29, 2025 |
| S-8 | Employee stock plan registration | Mar 5, 2025 | — |
| 10-K | Annual report | Mar 5, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Results of operations
|
Feb 20, 2025 | Feb 20, 2025 |
| 8-K |
Current report
Results of operations
|
Jan 15, 2025 | Jan 15, 2025 |
| 10-Q | Quarterly report | Nov 13, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 12, 2024 | Nov 12, 2024 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Oct 22, 2024 | Oct 21, 2024 |
| S-8 | Employee stock plan registration | Aug 30, 2024 | — |
| 10-Q | Quarterly report | Aug 13, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 13, 2024 | Aug 13, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Aug 6, 2024 | Aug 6, 2024 |
| 8-K/A |
Amended current report
Officer or director change
|
Jul 2, 2024 | Jun 24, 2024 |
| 8-K |
Current report
Impairment
|
Jun 27, 2024 | Jun 24, 2024 |
| 8-K |
Current report
Material agreement, Change to shareholder rights, Change in control, Officer or director change, Bylaw or fiscal year change
|
Jun 24, 2024 | Jun 21, 2024 |
| S-8 | Employee stock plan registration | Jun 21, 2024 | — |
| 8-K |
Current report
Officer or director change
|
Jun 12, 2024 | Jun 11, 2024 |
| 8-K/A |
Amended current report
Other events
|
Jun 6, 2024 | Jun 3, 2024 |
| SEC STAFF LETTER | Filing | Jun 3, 2024 | — |
| SEC STAFF LETTER | Filing | Jun 3, 2024 | — |
| SEC STAFF ACTION | Filing | Jun 3, 2024 | — |
| 8-K |
Current report
Other events
|
Jun 3, 2024 | Jun 3, 2024 |
| CERT | Filing | Jun 3, 2024 | — |
| 10-12B/A | Filing | Jun 3, 2024 | — |
| SEC STAFF LETTER | Filing | May 31, 2024 | — |
| CORRESP | Letter to the SEC | May 29, 2024 | — |
| CORRESP | Letter to the SEC | May 29, 2024 | — |
| 10-12B/A | Filing | May 29, 2024 | — |
| UPLOAD | Letter from the SEC | May 16, 2024 | — |
| CORRESP | Letter to the SEC | May 6, 2024 | — |
| 10-12B | Filing | May 6, 2024 | — |
| UPLOAD | Letter from the SEC | Apr 26, 2024 | — |
| DRSLTR | Filing | Apr 8, 2024 | — |
| DRS/A | Filing | Apr 8, 2024 | — |
| UPLOAD | Letter from the SEC | Mar 28, 2024 | — |
| DRS/A | Filing | Mar 11, 2024 | — |
| DRSLTR | Filing | Mar 8, 2024 | — |
| UPLOAD | Letter from the SEC | Feb 26, 2024 | — |
| DRS/A | Filing | Jan 30, 2024 | — |
| UPLOAD | Letter from the SEC | Jan 8, 2024 | — |
| DRS | Filing | Dec 11, 2023 | — |
| RW | Filing | Aug 23, 2021 | — |
| S-1/A | Amended registration statement | Sep 17, 2020 | — |
| S-1 | Registration statement | Sep 9, 2020 | — |
| DRS | Filing | Jul 31, 2020 | — |
| D/A | Filing | May 7, 2020 | — |
| D | Filing | Dec 12, 2019 | — |
| D | Filing | May 25, 2018 | — |
| D/A | Filing | Jan 11, 2018 | — |
| D/A | Filing | Nov 22, 2017 | — |
| D/A | Filing | Apr 26, 2017 | — |
| D | Filing | Mar 14, 2017 | — |
Showing 84 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Services-Medical Laboratories (SIC 8071)
- Listed as
- GRAL (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Sunnyvale, CA
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1699031
- Former names
- GRAIL, LLC (until Jun 12, 2024)
Other Services-Medical Laboratories companies
- Natera, Inc. NTRA
- Labcorp Holdings Inc. LH
- Quest Diagnostics Inc DGX
- Guardant Health, Inc. GH
- Caris Life Sciences, Inc. CAI
- RadNet, Inc. RDNT
- BillionToOne, Inc. BLLN
- CareDx, Inc. CDNA
Source: SEC EDGAR filings. This is company-reported data, not investment advice.